?Fenoldopam end Renal failure? (FENO-HSR)

AZIENDA OSPEDALIERA DI PERUGIA0 个研究点开始时间: 2012年5月14日最近更新: 2014年1月27日

适应症

试验速览

暂无简介。

•Sick undergo intervention cardiochirurgico who develop at any time during the postoperative hospital in Intensive Care, a screzio renal defined as ''R'' of the score of RIFLE (increase in creatinine of 50% compared to preoperatorio cardiochirurgico diuresis or with a less than 0 , 5 ml / kg / h for 6 hours) and a planned hospital in cardiac intensive care exceeding 24 hours). The upside of creatinine can happen at any time of hospitalization in Intensive Care (not necessarily in the first 24-48 hours) for any reason (low flow, sepsis ..).
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•-- Glaucoma -- Provided by the hospital intensive care within 24 hours -- Already taken the decision to place renal replacement treatment -- Already taken the decision not to therapeutic likely exitus -- Inclusion in other protocols randomized -- Age <18 years -- Lack of informed consent -- Patients who received fenoldopam in the previous 30 days -- Preoperative dialysis (temporary or permanent)

发起方